期刊文献+

固尔苏治疗72例新生儿呼吸窘迫综合征疗效观察 被引量:1

The therapeutic effect of curosurf on respiratory distress syndrome of neonates
下载PDF
导出
摘要 目的:探讨肺表面活性物质(PS)固尔苏(curosurf)对新生儿呼吸窘迫综合征(NRDS)的治疗效果。方法:将符合标准的72例患儿在给予相同综合治疗的基础上分为两组:观察组(固尔苏)及对照组(不用固尔苏),比较两组NRDS临床有效率、死亡率、呼吸机通气参数、机械通气时间、血气变化和胸部X线。结果:观察组临床有效率100%,死亡率、呼吸机通气参数、机械通气时间和胸部X线严重性明显低于对照组,均有显著性改善(P<0.05);用药后,抽血气分析监测pH、PaO2,及PaCO2,其较用药前均显著性改善(P<0.05)。结论:固尔苏能够显著提高NRDS疗效,使用安全。 Objective: To observe clinical therapeutic effect of curosurf for respiratory distress syndromeof neonates (NRDS).nethods: Seventy two neonates with NRDS were divided into two groups. Thirty six received curosurf and thirty six didn't received curosurf. All of the other supportive treatments were same in the both groups.The clinical effective rate, the death rate, the duration of mechanical ventilation, the pH,PaO2,PaCO2 of neonates after treatment and the severity of chest X-ray of neonates in the two groups were compared.Results:In the therapeutic group, the clinical effective rate and the death rate duration of mechanical ventilation were lower significantly than those in the control group.The pH,PaO2,PaCO2 of neonates in the treatment group were improved significantly after treatment (P〈0.05).The severity of NRDS on chest X-ray in therapeutic group was milder than that in control group.There were significant differences between the two groups (P〈0.05).Conclusion:The treatment with curosurf for neonates can improve therapeutic effect of NRDS.h is safe to use Curosurf for neonates.
出处 《中国医药导报》 CAS 2008年第20期80-81,共2页 China Medical Herald
关键词 肺表面活性物质 呼吸窘迫综合征 新生儿 Curosurf Respiratory disease syndrome Neonate
  • 相关文献

参考文献3

二级参考文献14

  • 1Stevens TP, Blennow M, Soil RF. Early suffactant administration with brief ventilation vs selective suffactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Cochrane Database Syst Rev, 2002,(2):CD003063.
  • 2Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev, 2000, (2) :CD000511.
  • 3Suresh GK, Soil RF. Exogenous surfactant therapy in newborn infants. Ann Acad Med Singapore, 2003,32(3):335-45.
  • 4Plavka R, Kopecky P, Sebron V, et al. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high- frequency oscillatory ventilation. Intensive Care Med, 2002,28(10) : 1483-90.
  • 5Yost CC, Soil RF. Early versus delayed selective surfactant treatment for neonatal respiratory, distress syndrome. Cochrane Database Syst Rev, 2000, (2) : CD001456.
  • 6MORLEY C J.Surfactant Treatment for Premeture Babies-a review of Clinical Trial[J].Arcl Dischild,1991,66:445.
  • 7李杰,樊寻梅,宋国维,李克华,郭在晨,叶鸿瑁,崔玉涛,甘小庄,王颍,朴梅花.肺表面活性制剂治疗新生儿呼吸窘迫综合征多中心临床观察[J].中华儿科杂志,2000,38(6):344-347. 被引量:118
  • 8罗先琼,周晓光.肺表面活性物质替代治疗对支气管肺发育不良发病的影响[J].中华围产医学杂志,2000,3(4):214-215. 被引量:3
  • 9王少华,匡凤梧,吴仕孝.新生儿呼吸窘迫综合征呼吸力学动态监测及临床意义[J].实用儿科临床杂志,2000,15(6):314-316. 被引量:8
  • 10宋国维.肺表面活性物质的代谢及临床应用[J].实用儿科临床杂志,2003,18(2):84-87. 被引量:71

共引文献36

同被引文献35

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部